MFDS — authorised 19 September 2008
- Marketing authorisation holder: GE HEALTHCARE
- Status: likely_approved
🇰🇷 Adreview in South Korea
MFDS authorised Adreview on 19 September 2008
Marketing authorisation
Adreview in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Adreview approved in South Korea?
Yes. MFDS authorised it on 19 September 2008.
Who is the marketing authorisation holder for Adreview in South Korea?
GE HEALTHCARE holds the South Korean marketing authorisation.